The Immunology of DLBCL
Cancers · 29.01.2023 · 15 (3) · 835
DOI: 10.3390/cancers15030835 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 29.01.2023. Verfasst von Taishi Takahara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute 480-1195, Japan. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Diffuse large B-cell lymphoma (DLBCL) is an aggressive malignancy and is the most common type of malignant lymphoid neoplasm. While some DLBCLs exhibit strong cell-autonomous survival and proliferation activity, others depend on interactions with non-malignant cells for their survival and proliferation. Recent next-generation sequencing studies have linked these interactions with the molecular classification of DLBCL. For example, germinal center B-cell-like DLBCL tends to show strong associations with follicular T cells and epigenetic regulation of immune recognition molecules, whereas activated B-cell-like DLBCL shows frequent genetic aberrations affecting the class I major histocompatibility complex. Single-cell technologies have also provided detailed information about cell–cell interactions and the cell composition of the microenvironment of DLBCL. Aging-related immunological deterioration, i.e., immunosenescence, also plays an important role in DLBCL pathogenesis, especially in Epstein-Barr virus-positive DLBCL. Moreover, DLBCL in “immune-privileged sites”—where multiple immune-modulating mechanisms exist—shows unique biological features, including frequent down-regulation of immune recognition molecules and an immune-tolerogenic tumor microenvironment. These advances in understanding the immunology of DLBCL may contribute to the development of novel therapies targeting immune systems.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute 480-1195, Japan.
- Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya 466-8550, Japan.
ORCID-Profile: Toyonori Tsuzuki
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Takahara, T., Nakamura, S., Tsuzuki, T., & Satou, A. (2023). The Immunology of DLBCL. Cancers, 15(3), 835. https://doi.org/10.3390/cancers15030835
Vancouver
Takahara T, Nakamura S, Tsuzuki T, Satou A. The Immunology of DLBCL. Cancers. 2023;15(3):835. doi:10.3390/cancers15030835
BibTeX
@article{Takahara2023,
author = {Takahara, Taishi and Nakamura, Shigeo and Tsuzuki, Toyonori and Satou, Akira},
title = {The Immunology of DLBCL},
journal = {Cancers},
year = {2023},
volume = {15},
number = {3},
pages = {835},
doi = {10.3390/cancers15030835}
}
EUVIMED